Delivery Order SPE2DE21D0005-SPE2D626F256G
Award Date 11/18/25
Potential Completion Date 11/21/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a $8,500 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain division on May 30, 2025. The delivery order, with an ultimate completion date of June 4, 2025, covers PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product. This award was made without a set-aside designation, indicating that Organogenesis competed as a standard...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a $3,400 fixed-price delivery order with economic price adjustment authority by the Defense Logistics Agency's Medical Supply Chain on October 1, 2025. The delivery order is for PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product, with an ultimate completion date of October 6, 2025. This award was made without any set-aside designation, indicating that Organogenesis competed as a...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $3,400 on July 17, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, which carries a fixed-price contract type with economic price adjustment provisions, is for PURAPLY AM XT EF, a 5-layer fenestrated advanced wound care product. The contract does not utilize a set-aside designation, indicating Organogenesis competed as a standard...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a $17.82K delivery order on September 9, 2025, for PURAPLY SX 6CM x 9CM wound care dressings. This fixed-price contract with economic price adjustment carries an ultimate completion date of September 12, 2025, and is being funded through the Medical Supply Chain, a defense-oriented federal agency. The award was made on a competitive basis with no set-aside designation, reflecting...
- Organogenesis Inc. was awarded a $8,500 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by July 28, 2025. The work will be performed at Organogenesis' headquarters in Canton, Massachusetts. No set-aside designation was utilized for this award, indicating...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, has been awarded a delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for PURAPLY AM XT 4.91X4.91 wound care dressings. The fixed-price delivery order, valued at $11,580.00, was awarded on August 15, 2025, with an ultimate completion date of August 20, 2025. The contract carries no set-aside designation, allowing the company to compete as a standard commercial vendor. The place of...
- Organogenesis Inc., a Canton, Massachusetts-based regenerative medicine company, was awarded a delivery order valued at $1,504.00 by the Defense Logistics Agency's Medical Supply Chain division on September 25, 2025. The contract, classified as a fixed-price award with economic price adjustment provisions, calls for the delivery of PURAPLY Micronized 500mg and is scheduled for completion by September 30, 2025. No small business or other set-aside designation was utilized in this competitive...
- Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts, was awarded a delivery order valued at $2,479.90 by the Defense Logistics Agency's Medical Supply Chain division on September 23, 2025. The contract, which operates under a fixed-price arrangement with economic price adjustment provisions, is for the supply of APLIGRAF, an advanced wound care and tissue regeneration product. The delivery order is scheduled for completion by September 26, 2025, and was awarded...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $8,500 delivery order to Organogenesis Inc. on August 4, 2025, for PURAPLY AM XT EF 5-layer fenestrated wound care dressing. The contract is fixed-price with economic price adjustment and carries an ultimate completion date of August 7, 2025. The award was made without a set-aside designation, allowing Organogenesis to compete as a standard commercial vendor. Performance will take place at the company's headquarters in...
- Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts, was awarded a delivery order valued at $2,088.00 for PURAPLY Micronized, 500mg on July 31, 2025, with an ultimate completion date of August 5, 2025. This fixed-price contract with economic price adjustment was awarded without set-aside designation by the Defense Logistics Agency's Medical Supply Chain division. PURAPLY Micronized is an advanced wound care product utilized in regenerative medicine...